BABAM2 and osteoporosis: In conclusion, our study elucidated the essentially negative role of Babam2 in osteoclastogenesis through both loss-of-function and gain-of-function strategies, suggesting that Babam2 was a potential novel therapeutic target to combat excessive bone resorption-related bone diseases, such as osteoporosis.